National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

    Search  
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
Related Pages
Kidney Cancer Home Page
NCI's gateway for information about kidney cancer.

Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.
Kidney Cancer Trial Results
6.  Sunitinib and Temsirolimus: Two New Targeted Drugs for Advanced Kidney Cancer
(Posted: 06/05/2006, Reviewed: 07/06/2009) - In separate clinical trials, two new targeted drugs - sunitinib (Sutent®) and temsirolimus - have shown positive results in patients with advanced kidney cancer, offering new standards of care, according to findings presented at the 2006 meeting of the American Society of Clinical Oncology.

7.  Regression of Advanced Kidney Cancer Seen with Allogeneic Stem Cell Transplantation
(Posted: 09/13/2000, Reviewed: 02/01/2005) - Researchers at the National Institutes of Health (NIH) report that advanced kidney cancer can be completely or partially reversed in some patients with the use of blood stem cell transplants from a healthy sibling donor.

8.  Less Chemotherapy Needed for Wilms Tumor Patients
(Posted: 05/01/1999, Reviewed: 02/01/2005) - People with Wilms tumor (a cancer of the kidney that most commonly occurs in children) can now receive fewer chemotherapy treatments with fewer side effects, according to a report in the January 1998 issue of the Journal of Clinical Oncology.
< Previous  1 2 

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov